Home › NDC Lookup › RxCUI directory › RxCUI 2670662

1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe — RxCUI 2670662

RxNorm drug concept · Semantic clinical drug
RxCUI 2670662 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2670662
Official name1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asefbemalenograstim alfa-vuxw 20 MG per 1 ML Prefilled Syringe; efbemalenograstim alfa-vuxw 20 MG in 1 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefil... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe RxCUI 2670662

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Efbemalenograstim alfa 2670630
    • Efbemalenograstim alfa-vuxw 2670656
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ryzneuta 2670664
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Efbemalenograstim alfa Prefilled Syringe 2670659
    • Efbemalenograstim alfa-vuxw Prefilled Syringe 2670661
    • Efbemalenograstim alfa Injectable Product 2670658
    • Efbemalenograstim alfa-vuxw Injectable Product 2670660
    • Efbemalenograstim alfa Prefilled Syringe [Ryzneuta] 2670667
    • Efbemalenograstim alfa-vuxw Prefilled Syringe [Ryzneuta] 2670668
    • Ryzneuta Injectable Product 2670666
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Efbemalenograstim alfa-vuxw 20 MG/ML SCDC · 2670657
  • Efbemalenograstim alfa Prefilled Syringe SCDF · 2670659
  • Efbemalenograstim alfa-vuxw Prefilled Syringe SCDFP · 2670661
  • Efbemalenograstim alfa Injectable Product SCDG · 2670658
  • Efbemalenograstim alfa-vuxw Injectable Product SCDGP · 2670660

Brand-Name Concepts

  • 1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta] SBD · 2670669
  • Efbemalenograstim alfa-vuxw 20 MG/ML [Ryzneuta] SBDC · 2670665
  • Efbemalenograstim alfa Prefilled Syringe [Ryzneuta] SBDF · 2670667
  • Efbemalenograstim alfa-vuxw Prefilled Syringe [Ryzneuta] SBDFP · 2670668
  • Ryzneuta Injectable Product SBDG · 2670666
  • Ryzneuta BN · 2670664

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2670662 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72893-0016-02 1 SYRINGE in 1 CARTON (72893-016-02) / 1 mL in 1 SYRINGE RYZNEUTA Acrotech Biopharma Inc 2023-11-23
Observed labelers: Acrotech Biopharma Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.